Compare Microchip Technology Inc. (MCHP) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs Tempus AI — how do they compare? Microchip Technology Inc. trades at $77 (market cap $42.37B), while Tempus AI trades at $70.22 (market cap $12.77B). The key difference: Microchip Technology Inc. is far larger — about 3.3× Tempus AI's market cap, and Microchip Technology Inc. pays a 2.33% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Microchip Technology Inc. for 62 Days and Tempus AI for 22 Days on average.
| MCHP | TEM | |
|---|---|---|
Market Cap | $42.37B | $12.77B |
Volume | 8,887,625 | 8,980,490 |
Sector | Technology | Broad Market / Factor |
52-Week High | $102.97 | $99.28 |
52-Week Low | $49.02 | $41.55 |
Typical Hold Time | 62 Days | 22 Days |
Enterprise Value | $47.49B | $13.40B |
Dividend Yield | 2.33% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Microchip Technology (MCHP) trades at $78.02, down 3.99% on the day, amid a bearish technical signal. The stock has beaten earnings estimates for the last three quarters, with Q3 2026 results pending. Revenue declined sharply in 2025 to $4.40B, resulting in a net loss, but 2026 projections show recovery. Analyst consensus is strongly bullish with a $110.50 price target. Recent news highlights expansion in Ethernet and power portfolios, plus the acquisition of Hailo to bolster edge AI capabilities.
MCHP's outlook is supported by robust analyst buy ratings and exposure to growing AI and data center demand. However, high valuation multiples, significant debt, and cyclical semiconductor risks pose challenges. Earnings growth in 2026 will be critical to justifying its premium valuation and driving shareholder returns.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
